| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |